Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity

Diagnostic Microbiology and Infectious Disease

Volumn 89, Issue 2, 2017, Pages 106-111

  Ko, Jae Hoon ^a,e   Müller, Marcel A ^b,c   Seok, Hyeri ^a   Park, Ga Eun ^a   Lee, Ji Yeon ^a   Cho, Sun Young ^a   Ha, Young Eun ^a   Baek, Jin Yang ^d   Kim, So Hyun ^d   Kang, Ji Man ^a   Kim, Yae Jean ^a   Jo, Ik Joon ^a   Chung, Chi Ryang ^a   Hahn, Myong Joon ^a   Drosten, Christian ^b,c   Kang, Cheol In ^a   Chung, Doo Ryeon ^a,d   Song, Jae Hoon ^a,d   Kang, Eun Suk ^a   Peck, Kyong Ran ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c German Centre for Infection Research (DZIF)   (Germany)

^d Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

^e The Armed Forces Capital Hospital   (South Korea)

Author keywords

Antibody; Middle East respiratory syndrome coronavirus; Prognosis; Serologic response

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HOSPITAL ADMISSION; HUMAN; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY FAILURE; SEROCONVERSION; SEROLOGY; SURVIVAL RATE; TERTIARY HEALTH CARE; UNIVERSITY HOSPITAL; BLOOD; CORONAVIRUS INFECTION; IMMUNOLOGY; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY;

ANTIBODIES, VIRAL; CORONAVIRUS INFECTIONS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; PNEUMONIA; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROCONVERSION;

EID: 85027411812     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2017.07.006     Document Type: Article

References (25)

1. Breakwell, L., Pringle, K., Chea, N., Allen, D., Allen, S., Richards, S., et al. Lack of transmission among close contacts of patient with case of Middle East respiratory syndrome imported into the United States, 2014. Emerg Infect Dis 21 (2015), 1128–1134.
2. Buchholz, U., Muller, M.A., Nitsche, A., Sanewski, A., Wevering, N., Bauer-Balci, T., et al. Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. Euro Surveill, 18, 2013.
3. Cho, S.Y., Kang, J.M., Ha, Y.E., Park, G.E., Lee, J.Y., Ko, J.H., et al. MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. Lancet 388 (2016), 994–1001.
4. Choe, P.G., Perera, R., Park, W.B., Song, K.H., Bang, J.H., Kim, E.S., et al. MERS-CoV antibody responses 1 year after symptom onset, South Korea, 2015. Emerg Infect Dis, 23, 2017.
5. Choi, W.S., Kang, C.I., Kim, Y., Choi, J.P., Joh, J.S., Shin, H.S., et al. Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea. Infect Chemother 48 (2016), 118–126.
6. Corman, V.M., Albarrak, A.M., Omrani, A.S., Albarrak, M.M., Farah, M.E., Almasri, M., et al. Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection. Clin Infect Dis 62 (2016), 477–483.
7. Corman, V.M., Eckerle, I., Bleicker, T., Zaki, A., Landt, O., Eschbach-Bludau, M., et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill, 17, 2012.
8. Corman, V.M., Muller, M.A., Costabel, U., Timm, J., Binger, T., Meyer, B., et al. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill, 17, 2012.
9. Kim, Y., Lee, S., Chu, C., Choe, S., Hong, S., Shin, Y., The characteristics of Middle Eastern respiratory syndrome coronavirus transmission dynamics in South Korea. Osong Public Health Res Perspect 7 (2016), 49–55.
10. Ko, J.H., Lee, J.Y., Baek, J.Y., Seok, H., Park, G.E., Lee, J.Y., et al. Serologic evaluation of MERS screening strategy for healthcare personnel during a hospital-associated outbreak. Infect Control Hosp Epidemiol 38 (2017), 234–238.
11. Ko, J.H., Müller, M.A., Seok, H., Park, G.E., Lee, J.Y., Cho, S.Y., et al. Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests. Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests, 2017, 10.1007/s10096-017-3043-3 [Epub ahead of print].
12. Ko, J.H., Park, G.E., Lee, J.Y., Lee, J.Y., Cho, S.Y., Ha, Y.E., et al. Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients. J Infect 73:5 (2016), 468–475.
13. Madani, T.A., Case definition and management of patients with MERS coronavirus in Saudi Arabia. Lancet Infect Dis 14 (2014), 911–913.
14. Meyer, B., Muller, M.A., Corman, V.M., Reusken, C.B., Ritz, D., Godeke, G.J., et al. Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg Infect Dis 20 (2014), 552–559.
15. Min, C.K., Cheon, S., Ha, N.Y., Sohn, K.M., Kim, Y., Aigerim, A., et al. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci Rep, 6, 2016, 25359.
16. Muller, M.A., Corman, V.M., Jores, J., Meyer, B., Younan, M., Liljander, A., et al. MERS coronavirus neutralizing antibodies in camels, eastern Africa, 1983-1997. Emerg Infect Dis 20 (2014), 2093–2095.
17. Muller, M.A., Meyer, B., Corman, V.M., Al-Masri, M., Turkestani, A., Ritz, D., et al. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis 15 (2015), 559–564.
18. Muth, D., Corman, V.M., Meyer, B., Assiri, A., Al-Masri, M., Farah, M., et al. Infectious Middle East respiratory syndrome coronavirus excretion and serotype variability based on live virus isolates from patients in Saudi Arabia. J Clin Microbiol 53 (2015), 2951–2955.
19. Park, G.E., Ko, J.H., Peck, K.R., Lee, J.Y., Lee, J.Y., Cho, S.Y., et al. Control of an outbreak of Middle East respiratory syndrome in a tertiary Hospital in Korea. Ann Intern Med 165 (2016), 87–93.
20. Park, W.B., Perera, R.A., Choe, P.G., Lau, E.H., Choi, S.J., Chun, J.Y., et al. Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea. Emerg Infect Dis 21 (2015), 2186–2189.
21. Payne, D.C., Iblan, I., Rha, B., Alqasrawi, S., Haddadin, A., Al Nsour, M., et al. Persistence of antibodies against Middle East respiratory syndrome coronavirus. Emerg Infect Dis 22 (2016), 1824–1826.
22. Raj, V.S., Mou, H., Smits, S.L., Dekkers, D.H., Muller, M.A., Dijkman, R., et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495 (2013), 251–254.
23. World Health Organization (WHO), WHO, Middle East respiratory syndrome coronavirus (MERS-CoV). http://www.who.int/emergencies/mers-cov/en/, 2017 [accessed on March 14, 2017].
24. Zaki, A.M., van Boheemen, S., Bestebroer, T.M., Osterhaus, A.D., Fouchier, R.A., Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367 (2012), 1814–1820.
25. Zumla, A., Hui, D.S., Perlman, S., Middle East respiratory syndrome. Lancet 386 (2015), 995–1007.